Clorox (NYSE:CLX) Releases FY 2025 Earnings Guidance

Clorox (NYSE:CLX) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 6.550-6.800 for the period, compared to the consensus estimate of 6.450. The company issued revenue guidance of $7.0 billion-$7.1 billion, compared to the consensus revenue estimate of $7.3 billion. Clorox also updated its FY25 guidance to $6.55-$6.80 EPS.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. BNP Paribas started coverage on shares of Clorox in a research note on Monday, June 24th. They issued an underperform rating and a $130.00 price objective on the stock. Argus upgraded Clorox to a hold rating in a report on Tuesday, June 4th. Barclays cut their target price on Clorox from $132.00 to $122.00 and set an underweight rating on the stock in a research note on Friday, July 19th. Evercore ISI lowered their price target on Clorox from $145.00 to $142.00 and set an underperform rating for the company in a research note on Wednesday, May 1st. Finally, TD Cowen started coverage on shares of Clorox in a research note on Tuesday, July 23rd. They set a sell rating and a $122.00 price objective on the stock. Six equities research analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company’s stock. According to MarketBeat, Clorox presently has an average rating of Hold and an average target price of $142.13.

Clorox Stock Performance

CLX stock traded up $2.14 during mid-day trading on Thursday, hitting $134.07. 2,626,396 shares of the company were exchanged, compared to its average volume of 1,249,933. Clorox has a 1-year low of $114.68 and a 1-year high of $169.14. The stock has a market capitalization of $16.65 billion, a PE ratio of 69.74, a price-to-earnings-growth ratio of 1.94 and a beta of 0.39. The business has a 50 day simple moving average of $133.60 and a 200-day simple moving average of $142.45. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73.

Clorox (NYSE:CLX) last released its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The business had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same period in the previous year, the company posted $1.51 EPS. The firm’s quarterly revenue was down 5.3% on a year-over-year basis. On average, equities analysts forecast that Clorox will post 5.91 earnings per share for the current year.

Clorox Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 30th. Shareholders of record on Wednesday, August 14th will be paid a dividend of $1.22 per share. This is an increase from Clorox’s previous quarterly dividend of $1.20. The ex-dividend date is Wednesday, August 14th. This represents a $4.88 annualized dividend and a yield of 3.64%. Clorox’s payout ratio is presently 248.71%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.